New Therapeutic Approved by FDA to Treat Prostate Cancer
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
Category: Policy
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
The U.S. Food and Drug Administration (FDA) recently added a new therapeutic to the armamentarium for oncologists treating patients...
The American Association for Cancer Research (AACR) is proud to support World Cancer Day, a yearly initiative of the...
On Friday, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic olaparib (Lynparza) for treating certain...
A little-talked-about provision of the 2010 Patient Protection and Affordable Care Act designed to improve access to innovative medical...
The relationship between cigarette smoking and lung cancer was first brought to the public’s attention more than 50 years...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the antibody–drug conjugate brentuximab vedotin (Adcetris)...
Recently, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic vemurafenib (Zelboraf) for treating certain adults...
Cigarette smoking is the leading cause of death from lung cancer in the United States. That’s why November, Lung...
Last week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic acalabrutinib (Calquence) for treating adults...